ALA arovella therapeutics limited

News: ALA Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    March 20 (Reuters) - Arovella Therapeutics Ltd (ALA) :

    • ALA-101 AND ONCARLYTICS COLLABORATION UPDATE
    • IMUGENE HAS ADVISED AROVELLA THAT IT NO LONGER WISHES TO CONTINUE COLLABORATION
    • PARTNERSHIP TO COMBINE ALA‐101 AND ONCARLYTICS HAS ENDED
    • NO FINANCIAL IMPACT FROM CESSATION OF COLLABORATION FOR AROVELLA
    • COLLABORATION WILL BE TERMINATED WITH IMMEDIATE EFFECT
    • TERMINATION WILL NOT IMPACT CO'S DEVELOPMENT OF ALA‐101 FOR CD19‐POSITIVE BLOOD CANCERS

    (([email protected];;))

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
8.3¢
Change
0.003(3.75%)
Mkt cap ! $99.27M
Open High Low Value Volume
8.1¢ 8.4¢ 8.1¢ $56.30K 680.6K

Buyers (Bids)

No. Vol. Price($)
5 236650 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 187486 5
View Market Depth
Last trade - 11.29am 16/09/2025 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.